34 results
Thumbnail

D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria

Thumbnail

D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap

Thumbnail

D1.495 - Noninvasive Monitoring of Cutaneous Molecular Changes During Improvement of Infantile Atopic Dermatitis: Application of Skin Surface Lipid RNA (SSL-RNA) Analysis

Thumbnail

D1.497 - An integrated multiomic insight to nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema

Thumbnail

D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment

Thumbnail

D1.499 - A clinically validated kinin biomarker assay to differentiate bradykinin-mediated from mast cell-mediated angioedema

Thumbnail

D1.503 - Immunoglobulin Abnormalities in Cronkhite-Canada Syndrome: A Focus on IgE and IgG4

Thumbnail

D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases

Thumbnail

D1.505 - Impact of patient factors on the stability of anti-IgE treatment response in chronic spontaneous urticaria

Thumbnail

D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study

Thumbnail

D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis

Thumbnail

D1.510 - Fecal Calprotectin as a Marker for Differentiating Children with Atopic Dermatitis With and Without Food Allergy

Thumbnail

D1.511 - Hereditary alpha-tryptasemia in chronic spontaneous urticaria: prevalence and clinical impact

Thumbnail

D1.512 - Culicoides allergen induced in vitro sulphidoleukotriene release correlates with clinical lesion severity in Icelandic horses affected with insect bite hypersensitivity

Thumbnail

D1.513 - Reduced Expression of PDCD4 on CD14+ Monocytes Correlates with Inflammatory Severity in Neonatal Sepsis: A Pilot Study

Thumbnail

D1.514 - Assessment of Serum Substance P Levels in Chronic Spontaneous Urticaria with Predominant Pruritus Refractory to H1-Antihistamines and Omalizumab

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)